Aaike van Oord
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aaike van Oord has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Annegien Broeks
Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands
1 shared publication - Henri van Luenen
Research – Cluster management, The Netherlands Cancer Institute, Amsterdam, The Netherlands
1 shared publication - Irith Kist
Board of Directors Administration and Legal Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands
1 shared publication - Marjanka K. Schmidt
Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, 1066 CX, The Netherlands.
1 shared publication - Miriam Beusink
Division of Molecular Pathology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
1 shared publication - Sonja van Scheijen
Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by Springer Nature in BMC Medical Ethics
- Vol. 27 (1)
Implementing broad consent for research with routinely collected clinical data and residual biosamples in a cancer hospital: using mixed methods approach to evaluate consent rates and patients’ perspectives
Patients are generally willing to contribute to research with routinely collected health data and residual biosamples, but transparency and being able to (
- 9 January 2026
- Published by Springer Nature in BMC Medical Ethics
- Vol. 27 (1)
Open AccessImplementing broad consent for research with routinely collected clinical data and residual biosamples in a cancer hospital: using mixed methods approach to evaluate consent rates and patients’ perspectives
Patients are generally willing to contribute to research with routinely collected health data and residual biosamples, but transparency and being able to (